Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
Caslo ApS is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Neurology
Quick Facts
HQ:Denmark
Founded:2002
Employees:905
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Global
Regulatory Approvals
Drug Approval DGGZVU
FDA · #APR-UIZPKI2E · 2019-11-01
Drug Approval XBKZFZ
Health Canada · #APR-D0H893JS · 2019-08-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
WHO GMP
World Health Organization
Cert #: CERT-MXIBU04J
Issued: 2020-06-07
Expires: 2025-07-12
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-PBEUOU3T
Issued: 2020-05-24
Expires: 2025-11-09
Health Canada GMP
Health Canada
Cert #: CERT-OIL93WKS
Issued: 2020-03-27
Expires: 2025-05-03
Loading CDMO intelligence...
Key facts about Caslo ApS
- Caslo ApS is headquartered in Denmark.
- Caslo ApS was founded in 2002.
- Caslo ApS has 905 employees.
- Caslo ApS's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Caslo ApS
Directory pages this company appears in, each with the full list of matching manufacturers.